Evidence map›Paper›PMID 38158757›Full record

ArticleESC heart failure2024

Changes over time in patient-reported outcomes in patients with heart failure.

Tiny Jaarsma, Naoko P Kato, Leonie Klompstra, Tuvia Ben Gal, Josiane Boyne, Eva Hägglund, Ercole Vellone, Andreas Hagenow, Lorraine S Evangelista, Jan Mårtensson and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tiny JaarsmaDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Naoko P KatoDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Leonie KlompstraDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Tuvia Ben GalHeart Failure Unit, Rabin Medical Center, Petah Tikva, Israel.
Josiane BoyneDepartment of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
Eva HägglundDepartment of Cardiology, Heart and Vascular Center, Karolinska University hospital, Stockholm, Sweden.
Ercole VelloneDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Andreas HagenowCenter of Internal Medicine Elsterwerda, Elsterwerda, Germany.
Lorraine S EvangelistaSchool of Nursing, University of Nevada, Las Vegas, NV, USA.
Jan MårtenssonDepartment of Nursing, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Anna StrömbergDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Funding

Medical Research Council of Southeast Sweden FORSS 474681Swedish Heart and Lung Association E085/12Swedish Heart and Lung Foundation 20130340Swedish Heart and Lung Foundation 20160439Swedish National Science Council 2016-01390Swedish National Science Council K2013-69X-22302-01-3Swedish National Science Council/Swedish Research Council for Health, Working Life and Welfare, VR-FORTE 2014-4100Vårdal Foundation 2014-0018
6 · The paper itself

Abstract

aimThis paper describes the trajectory during 1 year of four patient-reported outcomes (PROs), namely, sleep, depressive symptoms, health-related quality of life (HrQoL), and well-being, in patients with heart failure (HF), their relationship and the patient characteristics associated with changes in these PROs. METHODS AND

resultsData analyses of PROs from 603 patients (mean age 67 years; 29% female, 60% NYHA II) enrolled in the HF-Wii study. On short term, between baseline and 3 months, 16% of the patients experienced continuing poor sleep, 11% had sustained depressive symptoms, 13% had consistent poor HrQoL, and 13% consistent poor well-being. Across the entire 1-year period only 21% of the patients had good PRO scores at all timepoints (baseline, 3, 6, and 12 months). All others had at least one low score in any of the PROs at some timepoint during the study. Over the 12 months, 17% had consistently poor sleep, 17% had sustained symptoms of depression, 15% consistently rated a poor HrQoL, and 13% poor well-being. Different patient characteristics per PRO were associated with a poor outcomes across the 12 months. Age, education, New York Heart Association, and length of disease were related to two PRO domains and submaximal exercise capacity (6 min test), co-morbidity, and poor physical activity to one.

conclusionIn total, 79% of the patients with HF encountered problems related to sleep, depressive symptoms, HrQoL, and well-being at least once during a 1-year period. This underscores the need for continuous monitoring and follow-up of patients with HF and the need for dynamic adjustments in treatment and care regularly throughout the HF trajectory.

Indexed as

Heart FailureQuality of LifeAgedComorbidityDepressionFemaleHumansMalePatient Reported Outcome MeasuresHeart failurePatient‐reported outcomesQuality of lifeSymptoms

Identifiers

PMID38158757
PMCPMC10966260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.